Welcome to the McGill Diabetes Technologies Lab!
Our research is focused on the development and clinical assessment of learning algorithms with personalized insulin adjustments for multiple daily injection users and closed-loop artificial pancreas systems for insulin pump users.
Our lab utilizes an interdisciplinary approach across the fields of endocrinology, nutrition, pharmacology, mathematics, and control engineering.
Diabetes Quick Facts
In healthy individuals, the major hormone involved in blood glucose control is insulin, which reduces glucose levels. Type 1 diabetes is an autoimmune disease caused by the destruction of insulin-producing beta cells in the pancreas.
Type 1 diabetes accounts for 5‑15% of 400 million people with diabetes worldwide and strikes both children and adults at any age.
People with type 1 diabetes must carefully balance insulin doses (either by injections multiple times a day, or continuous infusion through a pump) with eating and other activities throughout the day and night.
With the currently available treatment options, less than one in five patients achieve glucose targets.